Ultragenyx Pharmaceutical (RARE) Interest & Investment Income (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) recorded Interest & Investment Income of $5 million in Q2 2026, down 16.7% from $6 million a year earlier and down 16.7% from the prior quarter.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Interest & Investment Income (2013 - 2026) Analysis & Trends
On a TTM basis, Ultragenyx Pharmaceutical's Interest & Investment Income came in at $23.38 million as of Jun 30, 2026, down 30.8% year-over-year; for FY2025, it came in at $25 million, down 32.4% from FY2024.
- Annual Interest & Investment Income has a five-year compound annual growth rate of 28.9% (FY2020 to FY2025).
- Across earlier years, Interest & Investment Income came in at $37 million in FY2024 (+37.0%), $27 million in FY2023 (+143.8%), $11.07 million in FY2022 (+474.4%) and $1.93 million in FY2021 (-72.6%).
- The Q2 2026 figure is the lowest quarterly Interest & Investment Income since Q3 2022.
- On a year-over-year basis, Interest & Investment Income has declined for six consecutive quarters, with an average decline of 6.9% over the last eight quarters.
- Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 753.7% in Q3 2022, against a decline of 69.5% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $6 million (Q1 2026), $6.51 million (Q4 2025) and $5.86 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Ultragenyx Pharmaceutical | 1.50 Bn | -302.56 Mn | 180.00 Mn | 5.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.00 Mn |
| Mar 31, 2026 | 6.00 Mn |
| Dec 31, 2025 | 6.51 Mn |
| Sep 30, 2025 | 5.86 Mn |
| Jun 30, 2025 | 6.00 Mn |
| Mar 31, 2025 | 7.00 Mn |
| Dec 31, 2024 | 10.04 Mn |
| Sep 30, 2024 | 10.73 Mn |
| Jun 30, 2024 | 7.40 Mn |
| Mar 31, 2024 | 8.82 Mn |
| Dec 31, 2023 | 8.87 Mn |
| Sep 30, 2023 | 5.88 Mn |
| Jun 30, 2023 | 5.96 Mn |
| Mar 31, 2023 | 6.29 Mn |
| Dec 31, 2022 | 6.20 Mn |
| Sep 30, 2022 | 3.48 Mn |
| Jun 30, 2022 | 899,000.00 |
| Mar 31, 2022 | 494,000.00 |
| Dec 31, 2021 | 440,000.00 |
| Sep 30, 2021 | 408,000.00 |
API Access
Ultragenyx Pharmaceutical Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();